RT Book, Section
A1 Lowery, William J.
A1 Chino, Junzo
A1 Havrilesky, Laura J.
A2 Karlan, Beth Y.
A2 Bristow, Robert E.
A2 Li, Andrew J.
SR Print(0)
ID 1106570660
T1 Vaginal Cancer
T2 Gynecologic Oncology: Clinical Practice and Surgical Atlas
YR 2015
FD 2015
PB McGraw-Hill Medical
PP New York, NY
SN 9780071749268
LK hemonc.mhmedical.com/content.aspx?aid=1106570660
RD 2024/04/23
AB Primary  vaginal  cancer  is  an  uncommon  gynecologic  malignancy  and  constitutes  only  1%  to  2%  of  gynecologic  malignancies.  Because  of  its  rarity,  there  are  specific  guidelines  for  the  diagnosis  of  primary  vaginal  cancer.  A  malignancy  located  in  the  vagina  and  not  involving  any  adjacent  pelvic  organs  is  considered  to  be  a  primary  vaginal  cancer.  If  the  malignancy  extends  to  the  cervix  or  vulva,  it  is  considered  a  primary  lesion  of  the  nonvaginal  site.  Based  on  the  observation  that  95%  of  patients  with  recurrent  cervical  cancer  will  experience  relapse  within  5  years,  all  squamous  cell  carcinomas  identified  in  the  vagina  within  this  period  are  defined  as  recurrences.  Only  those  squamous  cell  carcinomas  found  more  than  5  years  after  the  diagnosis  of  cervical  cancer  are  defined  as  primary  vaginal  cancers.1  If  there  is  a  history  of  endometrial  cancer,  a  diagnosis  of  adenocarcinoma  in  the  vagina  is  usually  considered  a  recurrence  regardless  of  the  time  from  primary  treatment.